Renaissance Capital LLC Legend Biotech Corp Transaction History

Renaissance Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 11, 2023	SELL	$43.42 - $57.37 $85,016 - $112,330	-1,958 Reduced 9.67%	18,300 $882,000
Q4 2022 Jan 06, 2023	SELL	$38.8 - $55.46 $2,328 - $3,327	-60 Reduced 0.3%	20,258 $0
Q3 2022 Oct 06, 2022	BUY	$38.15 - $57.1 $349,263 - $522,750	9,155 Added 82.01%	20,318 $829,000
Q2 2022 Jul 11, 2022	BUY	$33.54 - $55.0 $122,320 - $200,585	3,647 Added 48.52%	11,163 $614,000
Q1 2022 May 12, 2022	SELL	$31.02 - $48.18 $61,388 - $95,348	-1,979 Reduced 20.84%	7,516 $273,000
Q4 2021 Feb 01, 2022	BUY	$41.14 - $56.98 $390,624 - $541,025	9,495 New	9,495 $443,000

225

74.3M

279K

350K

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $5.49B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

Get notified when there are updates to the investment portfolio of Renaissance Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Capital LLC with notifications on news.